Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?
- PMID: 35437813
- DOI: 10.1111/ced.15232
Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?
Comment in
-
Strategies adopted in a southern Italian referral centre to reduce adalimumab discontinuation: comment on 'Can we increase the drug survival time of biologic therapies in hidradenitis suppurativa?'.Clin Exp Dermatol. 2022 Oct;47(10):1864-1865. doi: 10.1111/ced.15291. Epub 2022 Jul 12. Clin Exp Dermatol. 2022. PMID: 35699658 No abstract available.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
